-
A large basket of COVID-19 vaccine candidates is important: Renu Swarup
expresspharma
December 07, 2020
She said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and challenges.
-
COVID-19 vaccine will not be made mandatory: Joe Biden
expresspharma
December 07, 2020
Biden said he is willing to get inoculated in public to assuage any concerns about the vaccines’ efficacy and safety.
-
Pfizer seeks EUA for COVID-19 vaccine in India
expresspharma
December 07, 2020
Pfizer has written to the Drugs Controller General of India, applying for emergency use authorisation (EUA) of its coronavirus vaccine in India, the first to do so, CNN-News18 reported citing a government source.
-
Serum Institute applies for EUA for Covishield in India
expresspharma
December 07, 2020
According to sources, this vaccine is logistically feasible for distribution in the country's both urban and rural parts as it can be stored at two to eight degrees Celsius.
-
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.
prnasia
December 04, 2020
INOVIO announced the execution of an agreement with Kaneka Eurogentec S.A., an affiliate of Kaneka Corporation, for Eurogentec to manufacture INOVIO's COVID-19 vaccine candidate INO-4800 at their industry-leading GMP plasmid production scales.
-
COVID-19 vaccines may be less effective for racial minorities, suggest computer scientists
europeanpharmaceuticalreview
December 04, 2020
New research suggests that adding extra COVID-19 peptides to a dose of vaccine could increase effectiveness in populations that may not respond robustly to COVID-19 vaccines.
-
DSRU plans ‘post-authorisation’ study of COVID-19 vaccines in the UK
pharmatimes
December 04, 2020
The Drug Safety Research Unit – an independent academic unit based in Southampton, UK – is planning to conduct an active surveillance study on COVID-19 vaccine following regulatory authorisation.
-
DCGI probe finds no adverse event linked to SII’s Covid-19 vaccine
pharmaceutical-technology
December 04, 2020
The Drugs Controller General of India’s (DCGI) probe found that an alleged serious adverse event (SAE) suffered by a volunteer in Covid-19 vaccine trial of Serum Institute of India (SII) in Chennai was unrelated to the shot he received.
-
Batavia Biosciences and KU Leuven Join Forces
contractpharma
December 04, 2020
KU Leuven, a research institution and one of the top 50 universities in the world, and Batavia Biosciences, a contract development and manufacturing organization focused on delivering sustainable manufacturing solutions in the field of vaccines and ...
-
Inovio signs deal with Japan’s Kaneka for COVID-19 vaccine manufacturing
expresspharma
December 04, 2020
Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others.